Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | GLRA3 | O75311 | 1/20 | 0.39 |
| ▸ | GLRB | P48167 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | RXRB | P28702 | 1/20 | 0.39 |
| ▸ | HAAO | P46952 | 1/20 | 0.37 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | SELL | P14151 | 1/20 | 0.34 |
| ▸ | SELP | P16109 | 1/20 | 0.34 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.34 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.34 |
| ▸ | GABRP | O00591 | 1/20 | 0.33 |
| ▸ | GABRD | O14764 | 1/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.33 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.33 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6905613 | 0.98 | CYP1A2 (0.39) | CYP1A2GLRA3GLRBTDP1RXRB | |
| SCHEMBL4942021 | 0.89 | CYP1A2 (0.50) | CYP1A2TDP1RXRBHAAONR1H4 | |
| SCHEMBL332091 | 0.84 | GLRA3 (0.46) | CYP1A2GLRA3GLRBTDP1RXRB | |
| SCHEMBL4940867 | 0.84 | GLRA3 (0.46) | CYP1A2GLRA3GLRBTDP1RXRB | |
| SCHEMBL4939017 | 0.84 | GLRA3 (0.46) | CYP1A2GLRA3GLRBTDP1RXRB | |
| SCHEMBL29094363 | 0.83 | GLRA3 (0.44) | CYP1A2GLRA3GLRBTDP1RXRB | |
| SCHEMBL8340705 | 0.82 | GLRA3 (0.44) | CYP1A2GLRA3GLRBTDP1RXRB | |
| SCHEMBL9080891 | 0.82 | GLRA3 (0.44) | CYP1A2GLRA3GLRBTDP1RXRB | |
| SCHEMBL1406034 | 0.82 | GLRA3 (0.44) | CYP1A2GLRA3GLRBTDP1RXRB | |
| SCHEMBL20955847 | 0.82 | CYP1A2 (0.37) | CYP1A2GLRA3GLRBTDP1RXRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6010975-A | Catalyst composition for preparing 3-pentenoic ester from butadiene | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2000-01-04 | — | — | US | claimed |
| EP-1543015-A1 | PROCESS FOR THE PREPARATION OF ACID ESTERS | CROMPTON CORPORATION (US) | 2005-06-22 | — | — | EP | disclosed |
| US-6747167-B2 | REACTING A STERICALLY HINDERED PHENOL AND ACID HALIDE (PCL3) IN THE PRESENCE OF AN AMINE, THEN FURTHER REACTING WITH A CYCLIC ACID ACCEPTOR (DBN, DBU, DMAP OR DABCO) FOR AT LEAST A 98% CONVERSION TO THE PHOSPHITE | CROMPTON CORPORATION | 2004-06-08 | — | — | US | disclosed |
| WO-2004026885-A1 | PROCESS FOR THE PREPARATION OF ACID ESTERS | GENERAL ELECTRIC COMPANY (US) | 2004-04-01 | — | — | WO | disclosed |
| US-20040059151-A1 | Process for the preparation of acid esters | GENERAL ELECTRIC COMPANY | 2004-03-25 | — | — | US | disclosed |
| EP-1060479-A1 | SYNDIOTACTIC MONOVINYLIDENE AROMATIC POLYMER FILM | THE DOW CHEMICAL COMPANY (US) | 2000-12-20 | — | — | EP | disclosed |
| US-6010975-A | Catalyst composition for preparing 3-pentenoic ester from butadiene | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2000-01-04 | — | — | US | disclosed |
| WO-1999045547-A1 | SYNDIOTACTIC MONOVINYLIDENE AROMATIC POLYMER FILM | THE DOW CHEMICAL COMPANY (US) | 1999-09-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040059151-A1 | Process for the preparation of acid esters | HAO2, HAO1, DBF4 | CYP1A2 1377/4885GLRA3 3216/4885GLRB 4238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.